As a Scientific Analyst for Biomedtracker, David Dahan provides analytical comments on the major events of the day and answers queries from our customers in the pharma and investment community.
David covers a wide range of indications, including infectious diseases, cancer (hematologic, breast and ovarian) and obstetrics/gynecology. He looks at everything from the release of data from clinical trials to NIH Advisory Committee meetings. He also prepares post-meeting reports and interviews key opinion leaders.
In 2016 David covered the ASCO meeting, the world’s largest cancer research meeting.
Before joining us, David worked for 10 years as a Senior Scientist discovering novel small molecule flavour enhancers. He holds a BSc and PhD in Microbiology and Immunology from McGill University.